A business school alumnus has cycled over 16,000 km from Shanghai to London, to raise money for a children’s charity.
Matthieu Liard, a graduate of the CEMS Master’s in International Management programme and HEC Alumnus began the mammoth journey in March this year. Along with friend Oli Goulden, he cycled through 16 countries, four deserts and three mountain ranges.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64172-cems-alumnus-cycles-shanghai-london-charity
Eighteen years after opening its internationally prominent Center for Fetal Diagnosis and Treatment, The Children’s Hospital of Philadelphia (CHOP) celebrates 1,000 fetal surgeries – highly complex surgical interventions to repair birth defects in the womb. Approximately 4,000 fetal surgeries have been done worldwide, meaning a quarter of them have been performed at CHOP, the largest number of any hospital in the world.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62038-children-s-hospital-of-philadelphia-celebrates-1000-fetal-surgeries
Dune Medical Devices, Inc., announced today that its breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, the MarginProbe System, has received Premarket Approval (PMA) by the United States Food and Drug Administration. The technology significantly improves surgeons’ ability to intra-operatively identify
Pain can negatively affect a person’s quality of life and impede recovery from illness or injury. Recent research compiled by the American Massage Therapy Association (AMTA) suggests that massage can be a helpful pain management strategy for manually controlling symptoms in people suffering metastatic cancer and rheumatoid arthritis, among other illnesses, as well as post-cardiac surgery pain.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61665-amta-massage-therapy-for-pain-relief-cancer-arthritis-post-cardiac-surgery
Click: http://www.melogia.com Sarantos Releases Newest Rap Hip Hop Music Video That Will Answer The Break-Up Question - “Why”
Sarantos helps every woman out there who has ever wondered what a man thinks about after a relationship ends and when an ex refuses to answer them.
For most of his life when Sarantos had to go through a breakup, he would always turn to his dad for advice. Sadly, not too long ago Sarantos lost his devoted father after a hard-fought battle to lung cancer. This experience had a major impact on Sarantos' life, enabling him to overcome any obstacle that may present itself. The Chicago singer has since been driven to remain strong and positive not just for himself but also for his friends & fans.
The promising artist quickly responded to his fans' request by releasing the music video to his rap hip hop song "Why." With this newly released video, Sarantos hopes to encourage everyone to mend their heart and use their new-found understanding to move forward with their lives.
“Going through life’s hardships has given me the willpower to write songs and to sing from the heart,” says Sarantos. “I wouldn’t have had the passion or energy to strive for my dreams if it wasn’t for my loving family and friends. I know my father would have been very proud of me!”
Sarantos just released his 7th music video for “Why.” The song was released on July 1st, 2014.
Sarantos describes it as, “a hip and powerful rap song that answers the basic questions on every woman's mind about their relationship. Why does he love me? Why does he put up with me? Why does he stay here? Does he care for me? Does he really love me? The answer is lengthy and before he met you, he couldn't tell anyone why but now he can. He tells her exactly why!”
Sarantos has a strong motivation with his musical passion to raise money for charity. One-third of any music-related sales profits are going straight to charity. For “Why,” Sarantos has chosen the Aesthetic Surgery Education and Research Foundation. His love for helping others to improve has always been his motivation, and now, his music can reflect that.
Sarantos Facebook artist page:
https://www.facebook.com/Sarantosmelogia
Sarantos Twitter:
http://www.twitter.com/sarantosmelogia
Sarantos Youtube:
http://www.youtube.com/user/SarantosMelogia
Sarantos iTunes:
http://bit.ly/SarantosAppleStore
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
To promote the science behind obesity prevention and treatment, The Obesity Society (TOS) and the American Society for Metabolic and Bariatric Surgery (ASMBS) are combining resources to host the world’s pre-eminent meeting on obesity, ObesityWeek(SM) 2013, Nov. 11-16, at the Georgia World Congress Center in Atlanta, Georgia. For the first time, both organizations will co-locate their respective annual meetings under one roof for the most comprehensive agenda in obesity research, treatment and prevention.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55494-tos-and-asmbs-host-obesity-week-2013
In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
Bone and Joint Center is a center of hip excellence for arthroscopic surgery of sports-related injuries, FAI, hip impingement, ACL, labral tears and also minimally invasive anterior approach total hip replacement.
L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada.
For Latin America
Dr. Gioconda Gaudiano from Republic of Panama
Moon Children - Providing mobile surgery clinics to Indigenous people
This initiative provides free consultations, medical treatment and sun education via mobile surgery clinics to the 40,000 indigenous people from the Archipelago of San Blas, a region with the highest incidence of albinism in the world. Albinos can face severe skin problems, such as skin cancer, caused by UV light and sun exposure due to the lack of melanin in their skin. The mobile surgery clinics are able to travel to the Archipelago of San Blas, a community that often shuns medical treatment and avoids protective measures against skin cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Bone and Joint Center is a center of excellence for Direct Anterior hip replacement that is not a new surgery. Many surgeons have performed hip replacements through an anterior incision for decades but we are the best one's.
